利用回旋加速器生产 155Tb:155Gd 富集到什么程度才能用于临床?

IF 3 2区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Francesca Barbaro, Luciano Canton, Nikolay Uzunov, Laura De Nardo, Laura Melendez-Alafort
{"title":"利用回旋加速器生产 155Tb:155Gd 富集到什么程度才能用于临床?","authors":"Francesca Barbaro, Luciano Canton, Nikolay Uzunov, Laura De Nardo, Laura Melendez-Alafort","doi":"10.1186/s40658-024-00630-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><sup>155</sup>Tb represents a potentially useful radionuclide for diagnostic medical applications, but its production remains a challenging problem, in spite of the fact that many production routes have been already investigated and tested. A recent experimental campaign, conducted with low-energy proton beams impinging on a <sup>155</sup>Gd target with 91.9% enrichment, demonstrated a significant co-production of <sup>156g</sup>Tb, a contaminant of great concern since its half-life is comparable to that of <sup>155</sup>Tb and its high-energy γ emissions severely impact on the dose released and on the quality of the SPECT images. In the present investigation, the isotopic purity of the enriched <sup>155</sup>Gd target necessary to minimize the co-production of contaminant radioisotopes, in particular <sup>156g</sup>Tb, was explored using various computational simulations.</p><p><strong>Results: </strong>Starting from the recent experimental data obtained with a 91.9% <sup>155</sup>Gd-enriched target, the co-production of other Tb radioisotopes besides <sup>155</sup>Tb has been theoretically evaluated using the Talys code. It was found that <sup>156</sup>Gd, with an isotopic content of 5.87%, was the principal contributor to the co-production of <sup>156g</sup>Tb. The analysis also demonstrated that the maximum amount of <sup>156</sup>Gd admissible for <sup>155</sup>Tb production with a radionuclidic purity higher than 99% was 1%. A less stringent condition was obtained through computational dosimetry analysis, suggesting that a 2% content of <sup>156</sup>Gd in the target can be tolerated to limit the dose increase to the patient below the 10% limit. Moreover, it has been demonstrated that the imaging properties of the produced <sup>155</sup>Tb are not severely affected by this level of impurity in the target.</p><p><strong>Conclusions: </strong><sup>155</sup>Tb can be produced with a quality suitable for medical applications using low-energy proton beams and <sup>155</sup>Gd-enriched targets, if the <sup>156</sup>Gd impurity content does not exceed 2%. Under these conditions, the dose increase due to the presence of contaminant radioisotopes remains below the 10% limit and good quality images, comparable to those of <sup>111</sup>In, are guaranteed.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":"11 1","pages":"26"},"PeriodicalIF":3.0000,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286608/pdf/","citationCount":"0","resultStr":"{\"title\":\"<sup>155</sup>Tb production by cyclotrons: what level of <sup>155</sup>Gd enrichment allows clinical applications?\",\"authors\":\"Francesca Barbaro, Luciano Canton, Nikolay Uzunov, Laura De Nardo, Laura Melendez-Alafort\",\"doi\":\"10.1186/s40658-024-00630-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong><sup>155</sup>Tb represents a potentially useful radionuclide for diagnostic medical applications, but its production remains a challenging problem, in spite of the fact that many production routes have been already investigated and tested. A recent experimental campaign, conducted with low-energy proton beams impinging on a <sup>155</sup>Gd target with 91.9% enrichment, demonstrated a significant co-production of <sup>156g</sup>Tb, a contaminant of great concern since its half-life is comparable to that of <sup>155</sup>Tb and its high-energy γ emissions severely impact on the dose released and on the quality of the SPECT images. In the present investigation, the isotopic purity of the enriched <sup>155</sup>Gd target necessary to minimize the co-production of contaminant radioisotopes, in particular <sup>156g</sup>Tb, was explored using various computational simulations.</p><p><strong>Results: </strong>Starting from the recent experimental data obtained with a 91.9% <sup>155</sup>Gd-enriched target, the co-production of other Tb radioisotopes besides <sup>155</sup>Tb has been theoretically evaluated using the Talys code. It was found that <sup>156</sup>Gd, with an isotopic content of 5.87%, was the principal contributor to the co-production of <sup>156g</sup>Tb. The analysis also demonstrated that the maximum amount of <sup>156</sup>Gd admissible for <sup>155</sup>Tb production with a radionuclidic purity higher than 99% was 1%. A less stringent condition was obtained through computational dosimetry analysis, suggesting that a 2% content of <sup>156</sup>Gd in the target can be tolerated to limit the dose increase to the patient below the 10% limit. Moreover, it has been demonstrated that the imaging properties of the produced <sup>155</sup>Tb are not severely affected by this level of impurity in the target.</p><p><strong>Conclusions: </strong><sup>155</sup>Tb can be produced with a quality suitable for medical applications using low-energy proton beams and <sup>155</sup>Gd-enriched targets, if the <sup>156</sup>Gd impurity content does not exceed 2%. Under these conditions, the dose increase due to the presence of contaminant radioisotopes remains below the 10% limit and good quality images, comparable to those of <sup>111</sup>In, are guaranteed.</p>\",\"PeriodicalId\":11559,\"journal\":{\"name\":\"EJNMMI Physics\",\"volume\":\"11 1\",\"pages\":\"26\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-03-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286608/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40658-024-00630-6\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40658-024-00630-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

背景:155Tb 是一种潜在的有用放射性核素,可用于诊断医疗应用,但其生产仍然是一个具有挑战性的问题,尽管已经对许多生产途径进行了研究和测试。最近的一次实验活动是用低能质子束撞击富集度为 91.9% 的 155Gd 靶件,结果表明 156gTb 大量同时产生,由于 156gTb 的半衰期与 155Tb 的半衰期相当,而且其高能 γ 辐射严重影响释放的剂量和 SPECT 图像的质量,因此 156gTb 的污染问题备受关注。在本研究中,利用各种计算模拟探讨了富集 155Gd 靶件的同位素纯度,以尽量减少污染物放射性同位素(尤其是 156gTb)的共生:从最近使用富集度为 91.9% 的 155Gd 靶件获得的实验数据出发,使用 Talys 代码对 155Tb 以外的其他铽放射性同位素的共产情况进行了理论评估。结果发现,同位素含量为 5.87% 的 156Gd 是协同产生 156gTb 的主要因素。分析还表明,放射性核素纯度高于 99% 的 155Tb 生产所允许的 156Gd 最大含量为 1%。通过计算剂量学分析得出的一个较宽松的条件表明,靶材中的 156Gd 含量为 2%时,患者所受的剂量增加可限制在 10%以下。此外,研究还证明,生产出的 155Tb 的成像特性不会受到靶材中这一杂质含量的严重影响:结论:如果 156Gd 杂质含量不超过 2%,使用低能质子束和富集 155Gd 的靶材就能生产出适合医疗应用的 155Tb。在这些条件下,由于放射性同位素杂质的存在而导致的剂量增加仍低于10%的限制,并能保证获得与111In相媲美的高质量图像。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
155Tb production by cyclotrons: what level of 155Gd enrichment allows clinical applications?

Background: 155Tb represents a potentially useful radionuclide for diagnostic medical applications, but its production remains a challenging problem, in spite of the fact that many production routes have been already investigated and tested. A recent experimental campaign, conducted with low-energy proton beams impinging on a 155Gd target with 91.9% enrichment, demonstrated a significant co-production of 156gTb, a contaminant of great concern since its half-life is comparable to that of 155Tb and its high-energy γ emissions severely impact on the dose released and on the quality of the SPECT images. In the present investigation, the isotopic purity of the enriched 155Gd target necessary to minimize the co-production of contaminant radioisotopes, in particular 156gTb, was explored using various computational simulations.

Results: Starting from the recent experimental data obtained with a 91.9% 155Gd-enriched target, the co-production of other Tb radioisotopes besides 155Tb has been theoretically evaluated using the Talys code. It was found that 156Gd, with an isotopic content of 5.87%, was the principal contributor to the co-production of 156gTb. The analysis also demonstrated that the maximum amount of 156Gd admissible for 155Tb production with a radionuclidic purity higher than 99% was 1%. A less stringent condition was obtained through computational dosimetry analysis, suggesting that a 2% content of 156Gd in the target can be tolerated to limit the dose increase to the patient below the 10% limit. Moreover, it has been demonstrated that the imaging properties of the produced 155Tb are not severely affected by this level of impurity in the target.

Conclusions: 155Tb can be produced with a quality suitable for medical applications using low-energy proton beams and 155Gd-enriched targets, if the 156Gd impurity content does not exceed 2%. Under these conditions, the dose increase due to the presence of contaminant radioisotopes remains below the 10% limit and good quality images, comparable to those of 111In, are guaranteed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
EJNMMI Physics
EJNMMI Physics Physics and Astronomy-Radiation
CiteScore
6.70
自引率
10.00%
发文量
78
审稿时长
13 weeks
期刊介绍: EJNMMI Physics is an international platform for scientists, users and adopters of nuclear medicine with a particular interest in physics matters. As a companion journal to the European Journal of Nuclear Medicine and Molecular Imaging, this journal has a multi-disciplinary approach and welcomes original materials and studies with a focus on applied physics and mathematics as well as imaging systems engineering and prototyping in nuclear medicine. This includes physics-driven approaches or algorithms supported by physics that foster early clinical adoption of nuclear medicine imaging and therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信